Can pharmacist collaboration cut medication errors for patients on multiple drugs?
NCT ID NCT06902779
First seen Jun 24, 2026 · Last updated Sep 10, 2026 · Updated 3 times
Summary
This study tests whether closer collaboration between hospital and community pharmacists can reduce drug-related problems when patients taking many medications leave the hospital. Researchers will compare usual care to a process where the hospital pharmacist contacts the community pharmacy before discharge, shares the prescription, and provides extra information. The goal is to see if this reduces errors and improves patient and pharmacist satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Enhanced pharmacist collaboration (hospital pharmacist coordinates with community pharmacy at discharge)
- What this could lead to
- If it works, this could reduce medication errors and improve safety for patients taking multiple drugs after leaving the hospital.
- What could go wrong
- This is a small, early-stage study (150 participants) testing a process change, not a new drug. Results may not apply to other hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Sep 2025
- Finished
-
Sep 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients admitted to the internal medicine ward for more than 48 hours * Patients prescribed seven or more drugs at the time of screening * Patients discharged to home * Patients able to give informed consent as documented by signature Exclusion Criteria: * Patient discharged to another hospital, nursing home or rehabilitation clinic * Refusal of the community pharmacy to participate * Inability to sign consent and follow the procedures of the study, due to language problems, psychological disorders, dementia, alterations of consciousness and lack of judgement
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Polypharmacy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Riviera-Chablais, Vaud-Valais
Rennaz, Canton of Vaud, 1847, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a better medication review keep older adults out of the hospital?
- New program aims to cut unnecessary pills for dementia patients
- Hospital help: does a drug coordinator cut risky pill use?
- Learning to manage pills could save your kidneys
- EHR nudges aim to curb dangerous pill overload in seniors
- New program aims to cut dangerous drug combinations in seniors